Praxis Precision Medicines Inc R&D Day Transcript
Good morning, everyone. It's a real pleasure to be here with all of you. The government is up, so you don't have to worry about that. So we can focus on our update for the R&D Day at Praxis. It's incredibly humbling to be here with some of the updates we are going to be showing today.
Before I get started, I just want to make sure we're going to be making forward-looking statements. Refer to our SEC website for some of them. And together with myself, we're going to be joined by some of our senior colleagues at Praxis, but also by Dr. Espay, an expert in movement disorders; by Dr. French, that requires no introduction, an expert on the epilepsy field as well.
The format of the meeting is going to be focused on some of the key topics that are relevant for us right now as a company and shortly thereafter, for each one of the sections we're going to have a Q&A. I more than encourage, I ask you to participate during the Q&A session. And I think we can have a very robust discussion with our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |